COP29 outcomes fall short on climate health action

Agreements made at COP29 fell short of the ambition and focus needed to fully address the impacts of climate change on health and maximize the benefits of action, according to experts from the London School of Hygiene & Tropical Medicine (LSHTM).

Biodegradable diagnostic tests offer sustainable solution to plastic pollution

The global plastic pollution crisis and the fallout from the COVID-19 pandemic – where billions of single-use diagnostic tests were discarded – is prompting businesses

August 31, 2024

Catalyst licenses Santhera Pharmaceuticals’ vamorolone

Vamorolone has received orphan drug status in the US to treat Duchenne muscular dystrophy. Credit: StudioMolekuul / shutterstock.com. Santhera Pharmaceuticals and Catalyst Pharmaceuticals have signed

June 20, 2023

New forum launched to support behavioral research in laboratory animals

COST Action TEATIME have launched a new public forum for those wishing to delve deeper into scientific matters relating behavioral research in laboratory animals.

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.